Selection against Pathogenic mtDNA Mutations in a Stem Cell Population Leads to the Loss of the 3243A→G Mutation in Blood

Virginia Bioinformatics Institute, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
The American Journal of Human Genetics (Impact Factor: 10.93). 02/2008; 82(2):333-43. DOI: 10.1016/j.ajhg.2007.10.007
Source: PubMed


The mutation 3243A-->G is the most common heteroplasmic pathogenic mitochondrial DNA (mtDNA) mutation in humans, but it is not understood why the proportion of this mutation decreases in blood during life. Changing levels of mtDNA heteroplasmy are fundamentally related to the pathophysiology of the mitochondrial disease and correlate with clinical progression. To understand this process, we simulated the segregation of mtDNA in hematopoietic stem cells and leukocyte precursors. Our observations show that the percentage of mutant mtDNA in blood decreases exponentially over time. This is consistent with the existence of a selective process acting at the stem cell level and explains why the level of mutant mtDNA in blood is almost invariably lower than in nondividing (postmitotic) tissues such as skeletal muscle. By using this approach, we derived a formula from human data to correct for the change in heteroplasmy over time. A comparison of age-corrected blood heteroplasmy levels with skeletal muscle, an embryologically distinct postmitotic tissue, provides independent confirmation of the model. These findings indicate that selection against pathogenic mtDNA mutations occurs in a stem cell population.

Download full-text


Available from: David Samuels,
  • Source
    • "In the NZB mouse model, the rate of selection is currently held to be independent of initial heteroplasmy, and constant with time (Battersby et al., 2003). The human A3243G mtDNA mutation is lost continually from the blood of patients (Rahman et al., 2001; Rajasimha et al., 2008). To find out whether mtDNA dynamics change during organismal development or stay constant at all times, we applied an appropriate population genetic model for mtDNA segregation in our data. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The dynamics by which mitochondrial DNA (mtDNA) evolves within organisms are still poorly understood, despite the fact that inheritance and proliferation of mutated mtDNA cause fatal and incurable diseases. When two mtDNA haplotypes are present in a cell, it is usually assumed that segregation (the proliferation of one haplotype over another) is negligible. We challenge this assumption by showing that segregation depends on the genetic distance between haplotypes. We provide evidence by creating four mouse models containing mtDNA haplotype pairs of varying diversity. We find tissue-specific segregation in all models over a wide range of tissues. Key findings are segregation in postmitotic tissues (important for disease models) and segregation covering all developmental stages from prenatal to old age. We identify four dynamic regimes of mtDNA segregation. Our findings suggest potential complications for therapies in human populations: we propose "haplotype matching" as an approach to avoid these issues.
    Cell Reports 06/2014; 7(6). DOI:10.1016/j.celrep.2014.05.020 · 8.36 Impact Factor
    • "This parameter value was set at b = 0.66 based on 87 human mother–offspring pairs (Lott et al., 1990; Ciafaloni et al., 1992; Larsson et al., 1992; Martinuzzi et al., 1992; Tatuch et al., 1992; Zhu et al., 1992; Hammans et al., 1993, 1995; Piccolo et al., 1993; Howell et al., 1994; Santorelli et al., 1994; Harding et al., 1995; Houstek et al., 1995; Makelabengs et al., 1995; Black et al., 1996; Mak et al., 1996; Carelli et al., 1997; Uziel et al., 1997; Olsson et al., 1998; Onishi et al., 1998; Tanaka et al., 1998; Chinnery et al., 1999; White et al., 1999; Lien et al., 2001; Porto et al., 2001; Hurvitz et al., 2002; Wong et al., 2002; Kaplanova et al., 2004; Enns et al., 2006; Phasukkijwatana et al., 2006), including the following mutations: m.3243A>G (15 pairs), m.83446A>G (10 pairs), m.11778G>A (23 pairs), m.3460G>A (15 pairs), m.9883T>C (10 pairs) and m.8993T>G (14 pairs). Data from the A3243G mutation taken from blood samples were adjusted to correct for the known decrease in the A3243G mutation level in blood with age (Rajasimha et al., 2008). Of course, these pathogenic variants cause a range of different phenotypes, which could in principle affect the inheritance of that variant. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondrial medicine is one of the few areas of genetic disease where germ-line transfer is being actively pursued as a treatment option. All of the germ-line transfer methods currently under development involve some carry-over of the maternal mitochondrial DNA (mtDNA) heteroplasmy, potentially delivering the pathogenic mutation to the offspring. Rapid changes in mtDNA heteroplasmy have been observed within a single generation, and so any 'leakage' of mutant mtDNA could lead to mtDNA disease in future generations, compromising the reproductive health of the first generation, and leading to repeated interventions in subsequent generations. To determine whether this is a real concern, we developed a model of mtDNA heteroplasmy inheritance by studying 87 mother-child pairs, and predicted the likely outcome of different levels of 'mutant mtDNA leakage' on subsequent maternal generations. This showed that, for a clinical threshold of 60%, reducing the proportion of mutant mtDNA to <5% dramatically reduces the chance of disease recurrence in subsequent generations, but transmitting >5% mutant mtDNA was associated with a significant chance of disease recurrence. Mutations with a lower clinical threshold were associated with a higher risk of recurrence. Our findings provide reassurance that, at least from an mtDNA perspective, methods currently under development have the potential to effectively eradicate pathogenic mtDNA mutations from subsequent generations.
    Human Reproduction 01/2013; 28(3). DOI:10.1093/humrep/des439 · 4.57 Impact Factor
  • Source
    • "The mtDNAs in the simulation were copied with no preference to either wild-type or mutant. For simulation details see [46], [47]. The simulated cells were divided and the mtDNA molecules were individually randomly distributed to the two daughter cells. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Many pathogenic mitochondrial DNA mutations are heteroplasmic, with a mixture of mutated and wild-type mtDNA present within individual cells. The severity and extent of the clinical phenotype is largely due to the distribution of mutated molecules between cells in different tissues, but mechanisms underpinning segregation are not fully understood. To facilitate mtDNA segregation studies we developed assays that measure m.3243A>G point mutation loads directly in hundreds of individual cells to determine the mechanisms of segregation over time. In the first study of this size, we observed a number of discrete shifts in cellular heteroplasmy between periods of stable heteroplasmy. The observed patterns could not be parsimoniously explained by random mitotic drift of individual mtDNAs. Instead, a genetically metastable, heteroplasmic mtDNA segregation unit provides the likely explanation, where stable heteroplasmy is maintained through the faithful replication of segregating units with a fixed wild-type/m.3243A>G mutant ratio, and shifts occur through the temporary disruption and re-organization of the segregation units. While the nature of the physical equivalent of the segregation unit remains uncertain, the factors regulating its organization are of major importance for the pathogenesis of mtDNA diseases.
    PLoS ONE 12/2012; 7(12):e52080. DOI:10.1371/journal.pone.0052080 · 3.23 Impact Factor
Show more